An adenovirus vector-mediated reverse genetics system for influenza A virus generation (Q35947953)

11 August 2017

An adenovirus vector-mediated reverse genetics system for influenza A virus generation (English)

1 reference

11 August 2017

0 references

1 reference

influenza A virus

1 reference

4

Yoshihiro Kawaoka

1 reference

11 August 2017

Makoto Ozawa

1

1 reference

11 August 2017

Hideo Goto

series ordinal

2

1 reference

11 August 2017

Taisuke Horimoto

series ordinal

3

1 reference

11 August 2017

language of work or name

English

0 references

publication date

27 June 2007

1 reference

11 August 2017

1 reference

11 August 2017

81

1 reference

11 August 2017

17

1 reference

11 August 2017

9556-9559

1 reference

The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate.

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951417

Viral gene therapy strategies: from basic science to clinical application

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951417

An improved reverse genetics system for influenza A virus generation and its implications for vaccine production

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951417

Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951417

From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951417

Reverse genetics systems for the generation of segmented negative-sense RNA viruses entirely from cloned cDNA.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951417

Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951417

A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951417

Generation of influenza A virus from cloned cDNAs--historical perspective and outlook for the new millenium

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951417

A DNA transfection system for generation of influenza A virus from eight plasmids

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951417

"Ambisense" approach for the generation of influenza A virus: vRNA and mRNA synthesis from one template

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951417

Plasmid-driven formation of influenza virus-like particles

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951417

Rescue of influenza A virus from recombinant DNA.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951417

Experience with vero cells at Pasteur Mérieux Connaught.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951417

Development of a Vero cell-derived influenza whole virus vaccine.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951417

Avirulent Avian influenza virus as a vaccine strain against a potential human pandemic.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951417

Generation of influenza A viruses entirely from cloned cDNAs

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951417

A novel mammalian cell (Vero) derived influenza virus vaccine: development, characterization and industrial scale production.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951417

Development of a mammalian cell (Vero) derived candidate influenza virus vaccine

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951417

Mutations affecting the sensitivity of the influenza virus neuraminidase to 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951417

Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1951417

24 September 2018

Identifiers

DOI

10.1128/JVI.01042-07

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

17596315

1 reference